Is CTRY.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6
Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of CTRY.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate CTRY.F's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate CTRY.F's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CTRY.F?
Key metric: As CTRY.F barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.
The above table shows the Price to Book ratio for CTRY.F. This is calculated by dividing CTRY.F's market cap by their current
book value.
What is CTRY.F's PB Ratio?
PB Ratio
n/a
Book
CN¥155.06b
Market Cap
CN¥12.48b
CTRY.F key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Book vs Industry: Insufficient data to calculate CTRY.F's Price-To-Book Ratio vs. industry for valuation analysis.
Price to Book Ratio vs Fair Ratio
What is CTRY.F's PB Ratio
compared to its
Fair PB Ratio?
This is the expected PB Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
CTRY.F PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio
n/a
Fair PB Ratio
n/a
Price-To-Book vs Fair Ratio: Insufficient data to calculate CTRY.F's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst CTRY.F forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
US$0.18
US$0.078
-56.4%
30.6%
US$0.13
US$0.05
n/a
9
Nov ’25
n/a
US$0.08
0%
30.6%
US$0.13
US$0.052
n/a
9
Oct ’25
US$0.20
US$0.079
-60.3%
30.3%
US$0.13
US$0.052
n/a
9
Sep ’25
n/a
US$0.079
0%
30.4%
US$0.13
US$0.052
n/a
9
Aug ’25
n/a
US$0.077
0%
30.7%
US$0.13
US$0.051
n/a
9
Jul ’25
US$0.066
US$0.073
+10.5%
21.6%
US$0.10
US$0.051
n/a
10
Jun ’25
US$0.15
US$0.074
-52.1%
19.3%
US$0.10
US$0.051
n/a
10
May ’25
US$0.10
US$0.081
-19.0%
22.9%
US$0.12
US$0.051
n/a
11
Apr ’25
US$0.06
US$0.081
+35.0%
22.9%
US$0.12
US$0.051
n/a
11
Mar ’25
US$0.081
US$0.094
+15.4%
23.1%
US$0.13
US$0.064
n/a
12
Feb ’25
US$0.082
US$0.097
+19.0%
21.1%
US$0.13
US$0.065
n/a
12
Jan ’25
US$0.094
US$0.12
+23.5%
52.6%
US$0.32
US$0.066
n/a
13
Dec ’24
US$0.11
US$0.12
+4.2%
50.5%
US$0.31
US$0.064
n/a
13
Nov ’24
US$0.09
US$0.14
+54.6%
55.8%
US$0.31
US$0.064
n/a
15
Oct ’24
US$0.12
US$0.17
+39.9%
46.6%
US$0.31
US$0.069
US$0.20
16
Sep ’24
US$0.12
US$0.18
+47.5%
40.2%
US$0.31
US$0.096
n/a
17
Aug ’24
US$0.21
US$0.29
+39.6%
25.2%
US$0.43
US$0.12
n/a
17
Jul ’24
n/a
US$0.32
0%
12.8%
US$0.43
US$0.25
US$0.066
17
Jun ’24
n/a
US$0.32
0%
12.5%
US$0.44
US$0.26
US$0.15
17
May ’24
US$0.27
US$0.33
+23.3%
12.2%
US$0.44
US$0.26
US$0.10
17
Apr ’24
n/a
US$0.39
0%
42.9%
US$0.99
US$0.26
US$0.06
16
Mar ’24
US$0.32
US$0.47
+45.6%
34.9%
US$0.99
US$0.34
US$0.081
16
Feb ’24
US$0.37
US$0.47
+25.9%
34.8%
US$1.01
US$0.34
US$0.082
16
Jan ’24
US$0.34
US$0.45
+31.7%
39.1%
US$0.98
US$0.22
US$0.094
15
Dec ’23
US$0.37
US$0.44
+19.9%
40.4%
US$0.96
US$0.21
US$0.11
15
Nov ’23
US$0.15
US$0.40
+168.1%
45.3%
US$0.94
US$0.18
US$0.09
17
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.